10:20 | Russia: 9,455 daily cases, the lowest daily figure since October
Russia registered 9,455 new cases of COVID-19 in the last 24 hours, the lowest daily figure since last October, reported today the committee created by the Russian government to fight against the spread of the coronavirus. According to official statistics, in the past day across the country 336 people from the disease (up to a total of 98,809).
10:15 | Netherlands lifts ban on travelers from UK
The acting Dutch government lifted the ban on air and maritime passenger traffic with the United Kingdom on Tuesday, considering that this measure has lost its added value in the fight against the pandemic, since numerous cases of the disease have already been detected in the Netherlands. British mutation of the coronavirus.
10:03 | World Gymnastics in Tokyo before the Games, canceled
The International Gymnastics Federation today announced the cancellation of the world rhythmic gymnastics championship in Tokyo, which was intended to be a general test for this summer’s Olympics. The event, scheduled to start on May 4, was to be the last of a qualifying round that had also been previously canceled.
“For this reason, the decision has been made to cancel the World Cup in Japan, especially given current travel restrictions and difficulties around the world, as well as measures taken by the Japanese authorities to limit the rate of coronavirus infections. in the country before the Olympics, “said the federation.
The app connects via WeChat and downloads certified traveler medical data.
–
08:42 | China launches digital vaccination certificate to travel abroad
China today launched a mobile application so that its citizens can show vaccination certificates abroad and the results of COVID-19 tests that have been carried out. Last Sunday, Chinese Foreign Minister Wang Yi announced that the Asian country will issue health certificates for international travelers with the aim of “facilitating safe and orderly transit for people.”
It is an application that can be opened through the WeChat messaging program in which Chinese citizens can access the results of their nucleic acid and antibody tests, as well as vaccination certificates. Users must indicate which country they plan to visit or from which they return, although the program, called “Health Code against the epidemic, international version”, does not yet allow viewing of vaccination results and is restricted to Chinese citizens. .
08:34 | Germany: 4,252 new infections and 255 deaths in one day
Germany registered 4,252 new infections with coronavirus in the last 24 hours – about 300 more than a week ago – and 255 fatalities – compared to 358 last Tuesday. The maximum number of infections was registered on December 18 with 33,777 new infections in one day and the number of deaths on January 14, with 1,244.
In the country as a whole, the cumulative incidence in seven days stands at 67.5 new cases per 100,000 inhabitants, compared to 68.0 yesterday and 65.4 a week ago, according to updated data from the Robert Koch Institute (RKI) of virology. after midnight.
07:00 | They activate the fastest computer in the world to fight against the pandemic
The Japanese supercomputer Fugaku, recognized as the fastest in the world, began operating at full capacity this Tuesday (03.09.2021), as announced by its creators, who hope that the computer will allow progress in the investigation of the coronavirus.
Fugaku has been jointly developed by the Riken state scientific institute and the Japanese technology company Fujitsu, and was already partially activated last April to begin searching for potential drugs to treat COVID-19. From now on, the supercomputer will use the full capacity of its 415.5 petaflops, which allow it to complete 442,000 billion operations per second, according to the person in charge of the project, Hiroshi Matsumoto, in a ceremony held today in Kobe (western Japan), where the machine is located.
The vaccines that promise to defeat the coronavirus
Sputnik V, Instituto Gamaleya
The “Russian vaccine” aroused initial mistrust, but it has established itself as an option for a score of countries, including Argentina, Bolivia and Venezuela. The doubts arose due to its rapid approval, in August 2020, without having finished the tests. However, subsequent studies give high efficacy to this preparation, which uses adenoviral vectors to elicit immunity.
–
–
The vaccines that promise to defeat the coronavirus
BNT162b2, BioNTech/Pfizer
The vaccine from the German firm BioNTech uses a previously unpublished technology: lipid-covered mRNA. Simply explained, the vaccine “mimics” the form of SARS-CoV-2, eliciting the body’s response. In trials it showed high efficacy, which has been replicated in real conditions. The Pfizer firm acts in the alliance as a partner in manufacturing. It is used in a score of countries.
–
–
The vaccines that promise to defeat the coronavirus
mRNA-1273, Modern
The vaccine developed by the National Institute of Allergies and Infectious Diseases, the Advanced Biomedical Research and Development Authority (BARDA), and the Moderna firm uses technology similar to BioNTech’s. In trials it demonstrated an efficacy close to 95 percent. Unlike BioNTech, this formula can be stored at -20 degrees. It is used in the US and the European Union.
–
–
The vaccines that promise to defeat the coronavirus
AZD1222, Oxford-AstraZeneca
This vaccine developed by British and Swedish experts uses a modified chimpanzee adenovirus as a vector. The trials took place in the UK, Brazil, South Africa, Japan and India, and were interrupted a couple of times by suspicious deaths. However, its safety and efficacy ranging from 60 to 90 percent have been confirmed. It is used in Brazil, the EU and the UK.
–
–
The vaccines that promise to defeat the coronavirus
Ad5-nCoV, Cansino Biologics
This Chinese firm’s vaccine uses the common cold adenovirus to introduce an inactivated SARS-CoV-2 protein into the human body, eliciting an immune response. It has been used in China to inoculate soldiers of the People’s Army, and the tests were carried out in Russia, Pakistan, Mexico, Chile and Argentina. It is currently used in Mexico, Malaysia, and Indonesia. Use only one dose.
–
–
The vaccines that promise to defeat the coronavirus
CoronaVac, Sinovac Biotech
Like many vaccines that use inactivated viruses, this formula uses SARS-CoV-2 particles grown in cultures and inactivated before being injected into the body. The presence of these viruses triggers the immune reaction and prevents the disease from developing. Tested in Brazil, Indonesia, Chile and Turkey, it shows an effectiveness of more than 50 percent.
–
–
The vaccines that promise to defeat the coronavirus
BBV152, Bharat Biotech
Also with inactivated viruses, this vaccine developed by Bharat and the Indian Council for Medical Research is known as Covaxin, and has shown 81 percent efficacy in clinical trials. At the time, it sparked controversy for being inoculated in medical workers when the formula was still in phase I clinical trials. India is now seeking approval in other markets.
–
–
The vaccines that promise to defeat the coronavirus
BBIBP-CorV, Sinopharm
With trials in Argentina, Peru, the United Arab Emirates and other states, this Chinese inactivated virus vaccine has already been approved in Middle Eastern countries. According to studies, it would be 86 percent effective. Sinopharm is in the eye of controversy in Peru for having sent “courtesy vaccines” for politicians and for having donated thousands of dollars to the government.
–
–
The vaccines that promise to defeat the coronavirus
Ad26.COV2.S, Johnson & Johnson
Along with CanSino’s, it is the only single-dose vaccine to date. It is developed by the Belgian firm Janssen Pharmaceutica, a subsidiary of the American Johnson & Johnson. It can be stored in a normal refrigerator and has been shown to be more than 66 percent efficient. It uses a non-replicative viral vector derived from human adenovirus A26.
–
–
–
–
–
–
–
–
–
:quality(80)/cdn-kiosk-api.telegraaf.nl/e3ec5ca2-80ae-11eb-9885-0218eaf05005.jpg "Rico de Chilean suspected of collaboration between Taghi and Naoufal ‘Noffel’ F. | Inland")
